アジア太平洋地域の薬物送達デバイス市場 – 業界動向と2030年までの予測

Customize Your Report レポートをカスタマイズする Buy Now 今すぐ購入 Free Sample Report 無料サンプルレポート
Home Medical Devices アジア太平洋地域の薬物送達デバイス市場
Request for TOC TOC のリクエスト Speak to Analyst アナリストに相談する Buy Now今すぐ購入 Inquire Before Buying 事前に問い合わせる Free Sample Report 無料サンプルレポート

アジア太平洋地域の薬物送達デバイス市場 – 業界動向と2030年までの予測

  • Medical Devices
  • Published Report
  • Aug 2024
  • Asia-Pacific
  • 350 ページ
  • テーブル数: 381
  • 図の数: 30
Buy Now 今すぐ購入

アジア太平洋地域の薬物送達デバイス市場

Market Size in USD Billion

CAGR :  % Diagram

Diagram 予測期間
 2024 –2031
Diagram 市場規模（基準年）
 USD 320.82 Billion
Diagram Market Size (Forecast Year)
 USD 669.66 Billion
Diagram CAGR
 %
Diagram Major Markets Players
  • F. Hoffmann
  • La Roche
  • Mylan N.V.
  • Teva Pharmaceutical Industries
  • Sanofi

>アジア太平洋地域の薬物送達市場、製品タイプ別（経口薬物送達、肺薬物送達、注射薬物送達、眼科薬物送達、経鼻薬物送達、局所薬物送達、埋め込み型薬物送達、経粘膜薬物送達）、用途別（がん、糖尿病、呼吸器疾患、心血管疾患、その他）、エンドユーザー別（病院、専門クリニック、在宅ケア、その他）、流通チャネル別（病院薬局、小売薬局、オンライン薬局、その他）– 2030年までの業界動向と予測。

アジア太平洋地域の薬物送達デバイス市場

アジア太平洋地域の薬物送達市場の分析と規模

近年、薬物送達市場は予測期間中に急増すると予想されています。世界保健機関 (WHO) によると、慢性疾患の有病率は 2020 年末までに 57% 増加すると予想されています。慢性疾患の増加に対応して、ヘルスケア システムが高度な薬物送達技術にさらに重点を置くことへの要望が急速に高まっています。さらに、製品の安全性、有効性、および患者への配慮がますます重視されています。慢性疾患の治療のための日常的な注射薬の需要の高まりを満たす高度な技術の需要により、薬物送達市場は今後数年間で拡大するでしょう。                       

データブリッジ市場調査は、2022年に15億8,214万米ドルであったアジア太平洋の薬物送達市場は、2030年までに30億3,866万米ドルに達すると予測されており、2023年から2030年の予測期間中に8.50％のCAGRを達成すると予想されています。この経口薬物送達セグメントは、技術の進歩により、薬物送達市場の製品タイプセグメントを支配しています。市場価値、成長率、セグメンテーション、地理的範囲、主要プレーヤーなどの市場シナリオに関する洞察に加えて、データブリッジ市場調査によってまとめられた市場レポートには、詳細な専門家の分析、患者の疫学、パイプライン分析、価格設定分析、規制の枠組みも含まれています。

アジア太平洋地域の薬物送達市場の範囲とセグメンテーション

レポートメトリック

詳細

予測期間

2023年から2030年

基準年

2022

歴史的な年

2021 (2015～2020年にカスタマイズ可能)

定量単位

売上高（百万米ドル）、販売数量（個数）、価格（米ドル）

対象セグメント

製品タイプ (経口薬物送達、肺薬物送達、注射薬物送達、眼科薬物送達、経鼻薬物送達、局所薬物送達、埋め込み型薬物送達、経粘膜薬物送達)、用途 (がん、糖尿病、呼吸器疾患、心血管疾患、その他)、エンドユーザー (病院、専門クリニック、在宅ケア、その他)、流通チャネル (病院薬局、小売薬局、オンライン薬局、その他)

対象国

中国、日本、インド、韓国、シンガポール、マレーシア、オーストラリア、タイ、インドネシア、フィリピン、その他のアジア太平洋地域 (APAC)

対象となる市場プレーヤー

F. ホフマン・ラ・ロシュ社（スイス）、マイラン社（米国）、テバ製薬社（イスラエル）、サノフィ社（フランス）、ファイザー社（米国）、グラクソ・スミスクライン社（英国）、ノバルティス社（スイス）、サン・ファーマシューティカル・インダストリーズ社（インド）、バウシュ・ヘルス・カンパニーズ社（カナダ）、アストラゼネカ社（英国）、ジョンソン・エンド・ジョンソン社（米国）、メルク社（米国）、カディラ・ファーマシューティカルズ社（インド）、ドクター・レディーズ・ラボラトリーズ社（インド）、3M社（米国）、バイエル社（ドイツ）、アステラス製薬社（日本）、アッヴィ社（米国）、武田薬品工業株式会社（日本）

市場機会
  • 新興市場の増加
  • 研究開発活動の増加
  • 先端技術開発への投資増加
  • 革新的な製品の発売

市場の定義

薬物送達は、特定の標的部位に薬物を送達することで、人体に治療効果をもたらします。体内での薬物の速度、時間、放出を調整することで、安全性と有効性を高めることができます。薬物は、経口、注射、肺、鼻などのさまざまな経路で送達できます。ナノ粒子の特性は研究され、薬物送達システムの開発に使用され、薬物の配布プロセスがより効率的で時間の節約になりました。

アジア太平洋地域の薬物送達市場の動向

ドライバー

  • 慢性疾患の増加

糖尿病、がん、心血管疾患、呼吸器疾患などの慢性疾患の増加により、効果的な薬物送達システムの需要が高まっています。これらのシステムは、標的を絞った薬物送達に役立ち、治療結果と患者のコンプライアンスを改善します。

  • 技術の進歩

ナノテクノロジー、マイクロカプセル化、3D プリンティングなどの薬物送達技術の進歩は、この分野に革命をもたらしました。これらの進歩により、薬物の安定性の向上、放出の制御、および生物学的利用能の改善を実現する新しい薬物送達システムが開発されました。

  • 自己管理の需要が高まる

特に慢性疾患の場合、薬剤の自己投与の傾向が高まっています。使いやすく、便利で、自宅での自己投与を可能にする薬剤送達システムが人気を集めています。これは、人口の高齢化と長期的な薬剤管理の必要性を考えると特に重要です。

機会

  • 個別化医療に焦点を当てる

患者の遺伝子構成や特定の疾患特性に基づいて個々の患者に合わせた治療を行うことを目的とする個別化医療への移行により、標的薬物送達システムの需要が高まっています。これらのシステムにより、体内の特定の部位に薬物を送達し、治療効果を最大限に高めながら副作用を最小限に抑えることができます。

  • 研究開発投資の増加

製薬会社や研究機関は、新しい薬物送達技術の研究開発に多額の投資を行っています。これは、バイオアベイラビリティの低さ、薬物の劣化、患者の非順守など、従来の経口または注射製剤の限界を克服できる、改良された薬物送達システムの必要性によって推進されています。

制約/課題

  • 規制上のハードル

製薬業界は規制が厳しく、新しい薬物送達システムの承認を得るには、時間がかかり費用のかかるプロセスになることがあります。米国の FDA などの規制機関は、安全性と有効性に関して厳しい要件を課しており、新しい薬物送達技術の導入が遅れることがあります。

  • 知的財産問題

知的財産権の保護は、医薬品および薬物送達の分野では極めて重要です。企業は、イノベーションの特許取得において課題に直面したり、知的財産権をめぐって競合他社との法的紛争に遭遇したりする可能性があります。

このドラッグデリバリー市場レポートでは、最近の新しい開発、貿易規制、輸出入分析、生産分析、バリューチェーンの最適化、市場シェア、国内および現地の市場プレーヤーの影響、新たな収益源の観点から見た機会の分析、市場規制の変更、戦略的市場成長分析、市場規模、カテゴリ市場の成長、アプリケーションのニッチと優位性、製品の承認、製品の発売、地理的拡大、市場における技術革新などの詳細が提供されます。ドラッグデリバリー市場に関する詳細情報を取得するには、アナリスト概要について Data Bridge Market Research にお問い合わせください。当社のチームが情報に基づいた市場決定を行い、市場の成長を実現できるようお手伝いします。

最近の開発

  • 2022年3月、ノバルティスの子会社であるサンドスは、英国を拠点とする医療および薬物送達デバイス会社であるCoalesce Product Development Limitedの買収を発表しました。サンドスは、この契約の一環としてCoalesceの専門知識と資産を獲得しました。これにより、同社は呼吸器系医薬品のポートフォリオを拡大し、高品質で複雑な治療薬への患者のアクセスを向上させることができます。

アジア太平洋地域の薬物送達市場の展望

薬物送達市場は、製品タイプ、アプリケーション、エンドユーザー、流通チャネルに基づいてセグメント化されています。これらのセグメントの成長は、業界のわずかな成長セグメントを分析するのに役立ち、ユーザーに貴重な市場の概要と市場の洞察を提供し、コア市場アプリケーションを特定するための戦略的決定を下すのに役立ちます。

製品タイプ

応用

  • 癌
  • 糖尿病
  • 呼吸器疾患
  • 心血管疾患
  • その他

 エンドユーザー

  • 病院
  • 専門クリニック
  • ホームケア
  • その他

流通チャネル

  • 病院薬局
  • 小売薬局
  • オンライン薬局
  • その他

アジア太平洋地域の薬物送達市場の地域分析/洞察

薬物送達市場が分析され、上記のように製品タイプ、アプリケーション、エンドユーザー、流通チャネル別に市場規模の洞察と傾向が提供されます。

薬物送達市場レポートで取り上げられている国は、アジア太平洋地域 (APAC) の中国、日本、インド、韓国、シンガポール、マレーシア、オーストラリア、タイ、インドネシア、フィリピン、およびその他のアジア太平洋地域 (APAC) です。

中国は、医療施設の強固な基盤、市場における主要企業の強力な存在感、薬物送達製品の需要の高まり、この地域での研究活動の増加により、薬物送達市場を支配しています。   

中国は、意識を高めるための政府の取り組みの増加、医療観光の増加、地域での研究活動の拡大、大規模な未開拓市場の存在、大規模な人口プール、地域における質の高い医療への需要の高まりにより、2023年から2030年の予測期間中に大幅な成長が見込まれています。

レポートの国別セクションでは、市場の現在および将来の動向に影響を与える国内市場における個別の市場影響要因と規制の変更も提供しています。下流および上流のバリュー チェーン分析、技術動向、ポーターの 5 つの力の分析、ケース スタディなどのデータ ポイントは、各国の市場シナリオを予測するために使用される指標の一部です。また、国別データの予測分析を提供する際には、アジア太平洋ブランドの存在と可用性、および地元および国内ブランドとの競争が激しいか少ないために直面​​する課題、国内関税と貿易ルートの影響も考慮されます。   

ヘルスケアインフラの成長 導入ベースと新技術の浸透

ドラッグデリバリー市場では、各国の医療設備支出の増加、ドラッグデリバリー市場向け各種製品のインストールベース、ライフライン曲線を使用した技術の影響、医療規制シナリオの変化とそれらがドラッグデリバリー市場に与える影響など、詳細な市場分析も提供しています。データは、2015年から2020年までの履歴期間について入手可能です。

競争環境と薬物送達市場シェア分析

ドラッグデリバリー市場の競争状況は、競合他社ごとに詳細を提供します。含まれる詳細には、会社概要、会社の財務状況、収益、市場の可能性、研究開発への投資、新しい市場への取り組み、アジア太平洋地域でのプレゼンス、生産拠点と施設、生産能力、会社の強みと弱み、製品の発売、製品の幅と広さ、アプリケーションの優位性などがあります。提供されている上記のデータ ポイントは、ドラッグデリバリー市場に関連する会社の焦点にのみ関連しています。

薬物送達市場で活動している主要企業は次のとおりです。

  • F.ホフマン・ラ・ロシュ社（スイス）
  • マイランNV（米国）
  • テバ製薬工業株式会社（イスラエル）
  • サノフィ（フランス）、ファイザー（米国）
  • グラクソ・スミスクライン（英国）
  • ノバルティスAG（スイス）
  • サン・ファーマシューティカル・インダストリーズ（インド）
  • ドクター・レディーズ・ラボラトリーズ社（インド）
  • バウシュ・ヘルス・カンパニーズ（カナダ）
  • アストラゼネカ（英国）
  • ジョンソン・エンド・ジョンソン プライベート・リミテッド（米国）
  • メルク社（米国）
  • Cadila Pharmaceuticals（インド）
  • 3M（米国）
  • バイエルAG（ドイツ）
  • アステラス製薬株式会社（日本）
  • アッヴィ社（米国）
  • 武田薬品工業株式会社（日本）

SKU-

世界初のマーケットインテリジェンスクラウドに関するレポートにオンラインでアクセスする

Sample Image 画像をクリックすると拡大します
  • インタラクティブなデータ分析ダッシュボード
  • 成長の可能性が高い機会のための企業分析ダッシュボード
  • カスタマイズとクエリのためのリサーチアナリストアクセス
  • インタラクティブなダッシュボードによる競合分析
  • 最新ニュース、更新情報、トレンド分析
  • 包括的な競合追跡のためのベンチマーク分析のパワーを活用
デモのリクエスト

目次

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF THE ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATIONS

1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 DBMR TRIPOD DATA VALIDATION MODEL

2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.6 MULTIVARIATE MODELLING

2.7 MARKET END USER COVERAGE GRID

2.8 PRODUCT TYPE LIFELINE CURVE

2.9 DBMR MARKET POSITION GRID

2.1 VENDOR SHARE ANALYSIS

2.11 SECONDARY SOURCES

2.12 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PORTERS FIVE FORCES

4.2 PESTEL ANALYSIS

5 REGULATORY FRAMEWORK

6 MARKET OVERVIEW

6.1 DRIVERS

6.1.1 RISING PREVALENCE OF CHRONIC DISEASE AND NON-CHRONIC DISEASE

6.1.2 GROWTH IN THE DEVELOPMENT OF BIOLOGICS DRUGS DEVICES

6.1.3 INCREASING AWARENESS ABOUT DIAGNOSIS AND TREATMENT

6.1.4 INCREASED FOCUS ON PERSONALIZED MEDICINE AND DEVICES

6.2 RESTRAINTS

6.2.1 RISK OF NEEDLE-STICK INJURIES AND SIDE EFFECTS

6.2.2 HIGH COSTS OF INJECTABLE DRUGS

6.2.3 STRINGENT REGULATORY SCENARIO

6.3 OPPORTUNITIES

6.3.1 RISING ACCEPTANCE OF SELF-ADMINISTERING DRUG DEVICES

6.3.2 RISING DEMAND FOR BIOSIMILAR AND GENERIC DRUGS

6.3.3 THERAPEUTIC ADVANCEMENTS IN THE FIELD OF DRUG DELIVERY

6.4 CHALLENGES

6.4.1 SIDE EFFECTS OF DRUG DELIVERY SYSTEMS

6.4.2 INCREASE IN THE NUMBER OF ALTERNATIVES OF DRUG DELIVERY

7 ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE

7.1 OVERVIEW

7.2 ORAL DRUG DELIVERY

7.2.1 SOLID ORAL DRUGS

7.2.1.1 TABLETS

7.2.1.2 CAPSULES

7.2.1.3 PILLS

7.2.1.4 POWDERS

7.2.2 LIQUID ORAL DRUGS

7.2.2.1 SYRUPS

7.2.2.2 SOLUTIONS

7.2.3 SEMI SOLID ORAL DRUGS

7.2.3.1 GELS

7.2.3.2 EMULSIONS

7.2.3.3 ELIXIRS

7.3 INJECTABLE DRUG DELIVERY

7.3.1 INJECTABLE DRUG DELIVERY FORMULATIONS

7.3.1.1 CONVENTIONAL DRUG DELIVERY FORMULATIONS

7.3.1.2 NOVEL DRUG DELIVERY FORMULATIONS

7.3.1.3 LONG ACTING INJECTION FORMULATIONS

7.3.2 INJECTABLE DRUG DELIVERY DEVICES

7.3.2.1 CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES

7.3.2.1.1 BY MATERIAL

7.3.2.1.1.1 GLASS

7.3.2.1.1.2 PLASTIC

7.3.2.1.2 BY PRODUCT TYPE

7.3.2.1.2.1 FILLABLE

7.3.2.1.2.2 PRE-FILLED

7.3.2.1.3 BY USABILITY

7.3.2.1.3.1 REUSABLE SYRINGES

7.3.2.1.3.2 DISPOSABLE SYRINGES

7.3.2.2 SELF INJECTION DRUG DELIVERY DEVICES

7.3.2.2.1 NEEDLE FREE INJECTORS

7.3.2.2.2 WEARABLE INJECTORS

7.3.2.2.3 PEN INJECTOR

7.3.2.2.4 AUTO INJECTORS

7.3.2.2.5 OTHERS

7.4 TOPICAL DRUG DELIVERY

7.4.1 TRANSDERMAL DRUG DELIVERY FORMULATIONS

7.4.1.1 SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS

7.4.1.1.1 OINTMENTS

7.4.1.1.2 CREAMS

7.4.1.1.3 LOTIONS

7.4.1.1.4 GELS

7.4.1.1.5 PASTES

7.4.1.2 LIQUID TOPICAL DRUG DELIVERY FORMULATIONS

7.4.1.2.1 SUSPENSIONS

7.4.1.2.2 SOLUTIONS

7.4.1.3 SOLID TOPICAL DRUG DELIVERY FORMULATIONS

7.4.1.3.1 POWDER

7.4.1.3.2 SUPPOSITORS

7.5 OPHTHALMIC DRUG DELIVERY

7.5.1 OCCULAR DRUG DELIVERY FORMULATIONS

7.5.1.1 LIQUID OCCULAR DRUG DELIVERY FORMULATIONS

7.5.1.1.1 SOLUTIONS

7.5.1.1.2 SUSPENSIONS

7.5.1.2 SEMI SOLID OCCULAR DRUG DELIVERY FORMULATIONS

7.5.1.2.1 GELS

7.5.1.2.2 OINTMENTS

7.5.2 OCCULAR DRUG DELIVERY DEVICES

7.6 NASAL DRUG DELIVERY

7.6.1 NASAL DROPS

7.6.2 NASAL SPRAYS

7.6.3 NASAL POWDERS

7.6.4 NASAL GELS

7.7 PULMONARY DRUG DELIVERY

7.7.1 METERED DOSE INHALERS (MDI)

7.7.2 DRY POWDER INHALERS (DPI)

7.7.3 NEBULIZERS

7.7.3.1 JET NEBULIZERS

7.7.3.2 ULTRASONIC NEBULIZERS

7.7.3.3 SOFT MIST NEBULIZERS

7.8 TRANSMUCOSAL DRUG DELIVERY

7.8.1 ORAL TRANSMUCOSAL DRUG DELIVERY

7.8.1.1 BUCCAL DRUG DELIVERY

7.8.1.2 SUBLINGUAL DRUG DELIVERY

7.8.2 OTHER TRANSMUCOSAL DRUG DELIVERY

7.8.2.1 RECTAL TRANSMUCOSAL DRUG DELIVERY

7.8.2.2 VAGINAL TRANSMUCOSAL DRUG DELIVERY

7.9 IMPLANTABLE DRUG DELIVERY

7.9.1 PASSIVE IMPLANTABLE DRUG DELIVERY DEVICES

7.9.2 ACTIVE IMPLANTABLE DRUG DELIVERY DEVICES

8 ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET, BY END USER

8.1 OVERVIEW

8.2 HOSPITALS

8.3 HOME HEALTHCARE

8.4 CLINICS

8.5 COMMUNITY HEALTHCARE

8.6 OTHERS

9 ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL

9.1 OVERVIEW

9.2 DIRECT TENDERS

9.3 HOSPITAL PHARMACIES

9.4 PHARMACY STORES

9.5 ONLINE PHARMACY

10 ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET, BY REGION

10.1 ASIA-PACIFIC

10.1.1 JAPAN

10.1.2 CHINA

10.1.3 INDIA

10.1.4 SOUTH KOREA

10.1.5 AUSTRALIA

10.1.6 THAILAND

10.1.7 MALAYSIA

10.1.8 SINGAPORE

10.1.9 INDONESIA

10.1.10 PHILIPPINES

10.1.11 REST OF ASIA-PACIFIC

11 ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET: COMPANY LANDSCAPE

11.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC

12 SWOT ANALYSIS

13 COMPANY PROFILE

13.1 JOHNSON & JOHNSON SERVICES, INC.

13.1.1 COMPANY SNAPSHOT

13.1.2 REVENUE ANALYSIS

13.1.3 COMPANY SHARE ANALYSIS

13.1.4 PRODUCT PORTFOLIO

13.1.5 RECENT DEVELOPMENTS

13.2 NOVARTIS AG

13.2.1 COMPANY SNAPSHOT

13.2.2 REVENUE ANALYSIS

13.2.3 COMPANY SHARE ANALYSIS

13.2.4 PRODUCT PORTFOLIO

13.2.5 RECENT DEVELOPMENTS

13.3 F. HOFFMANN-LA ROCHE LTD

13.3.1 COMPANY SNAPSHOT

13.3.2 REVENUE ANALYSIS

13.3.3 COMPANY SHARE ANALYSIS

13.3.4 PRODUCT PORTFOLIO

13.3.5 RECENT DEVELOPMENT

13.4 BAYER AG

13.4.1 COMPANY SNAPSHOT

13.4.2 REVENUE ANALYSIS

13.4.3 COMPANY SHARE ANALYSIS

13.4.4 PRODUCT PORTFOLIO

13.5 PFIZER INC.

13.5.1 COMPANY SNAPSHOT

13.5.2 REVENUE ANALYSIS

13.5.3 COMPANY SHARE ANALYSIS

13.5.4 PRODUCT PORTFOLIO

13.5.5 RECENT DEVELOPMENT

13.6 3M

13.6.1 COMPANY SNAPSHOT

13.6.2 REVENUE ANALYSIS

13.6.3 PRODUCT PORTFOLIO

13.6.4 RECENT DEVELOPMENTS

13.7 ABBVIE INC.

13.7.1 COMPANY SNAPSHOT

13.7.2 REVENUE ANALYSIS

13.7.3 PRODUCT PORTFOLIO

13.7.4 RECENT DEVELOPMENTS

13.8 AMGEN INC.

13.8.1 COMPANY SNAPSHOT

13.8.2 REVENUE ANALYSIS

13.8.3 PRODUCT PORTFOLIO

13.8.4 RECENT DEVELOPMENTS

13.9 BD

13.9.1 COMPANY SNAPSHOT

13.9.2 REVENUE ANALYSIS

13.9.3 PRODUCT PORTFOLIO

13.9.4 RECENT DEVELOPMENT

13.1 ELCAM MEDICAL

13.10.1 COMPANY SNAPSHOT

13.10.2 PRODUCT PORTFOLIO

13.10.3 RECENT DEVELOPMENT

13.11 ENABLE INJECTIONS

13.11.1 COMPANY SNAPSHOT

13.11.2 PRODUCT PORTFOLIO

13.11.3 RECENT DEVELOPMENTS

13.12 GERRESHEIMER AG

13.12.1 COMPANY SNAPSHOT

13.12.2 REVENUE ANALYSIS

13.12.3 PRODUCT PORTFOLIO

13.12.4 RECENT DEVELOPMENTS

13.13 GSK PLC.

13.13.1 COMPANY SNAPSHOT

13.13.2 REVENUE ANALYSIS

13.13.3 PRODUCT PORTFOLIO

13.13.4 RECENT DEVELOPMENTS

13.14 INSULET CORPORATION

13.14.1 COMPANY SNAPSHOT

13.14.2 REVENUE ANALYSIS

13.14.3 PRODUCT PORTFOLIO

13.14.4 RECENT DEVELOPMENTS

13.15 MEDMIX

13.15.1 COMPANY SNAPSHOT

13.15.2 REVENUE ANALYSIS

13.15.3 PRODUCT PORTFOLIO

13.15.4 RECENT DEVELOPMENTS

13.16 MERCK & CO., INC.

13.16.1 COMPANY SNAPSHOT

13.16.2 REVENUE ANALYSIS

13.16.3 PRODUCT PORTFOLIO

13.16.4 RECENT DEVELOPMENT

13.17 ORASURE TECHNOLOGIES INC.

13.17.1 COMPANY SNAPSHOT

13.17.2 REVENUE ANALYSIS

13.17.3 PRODUCT PORTFOLIO

13.17.4 RECENT DEVELOPMENT

13.18 SANOFI

13.18.1 COMPANY SNAPSHOT

13.18.2 REVENUE ANALYSIS

13.18.3 PRODUCT PORTFOLIO

13.18.4 RECENT DEVELOPMENTS

13.19 SMC LTD.

13.19.1 COMPANY SNAPSHOT

13.19.2 REVENUE ANALYSIS

13.19.3 PRODUCT PORTFOLIO

13.19.4 RECENT DEVELOPMENTS

13.2 VIVO SMART MEDICAL DEVICES LTD.

13.20.1 COMPANY SNAPSHOT

13.20.2 PRODUCT PORTFOLIO

13.20.3 RECENT DEVELOPMENT

13.21 WEST PHARMACEUTICAL SERVICES, INC.

13.21.1 COMPANY SNAPSHOT

13.21.2 REVENUE ANALYSIS

13.21.3 PRODUCT PORTFOLIO

13.21.4 RECENT DEVELOPMENT

14 QUESTIONNAIRE

15 RELATED REPORTS

表のリスト

TABLE 1 LIST OF FDA APPROVED BIOLOGICS, IN 2022

TABLE 2 10 MOST EXPENSIVE DRUGS IN THE U.S. (IN USD MILLION)

TABLE 3 ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 4 ASIA-PACIFIC ORAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 5 ASIA-PACIFIC ORAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 6 ASIA-PACIFIC SOLID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 7 ASIA-PACIFIC LIQUID ORAL DRUG IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 8 ASIA-PACIFIC SEMI SOLID ORAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 9 ASIA-PACIFIC INJECTABLE DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 10 ASIA-PACIFIC INJECTABLE DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 11 ASIA-PACIFIC INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 12 ASIA-PACIFIC INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 13 ASIA-PACIFIC CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2022-2031 (USD MILLION)

TABLE 14 ASIA-PACIFIC CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE 2022-2031 (USD MILLION)

TABLE 15 ASIA-PACIFIC CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY USABILITY, 2022-2031 (USD MILLION)

TABLE 16 ASIA-PACIFIC SELF INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 17 ASIA-PACIFIC TOPICAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 18 ASIA-PACIFIC TOPICAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 19 ASIA-PACIFIC TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 20 ASIA-PACIFIC SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 21 ASIA-PACIFIC LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 22 ASIA-PACIFIC SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 23 ASIA-PACIFIC OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 24 ASIA-PACIFIC OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 25 ASIA-PACIFIC OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 26 ASIA-PACIFIC LIQUID OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 27 ASIA-PACIFIC SEMI SOLID OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 28 ASIA-PACIFIC NASAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 29 ASIA-PACIFIC NASAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 30 ASIA-PACIFIC PULMONARY DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 31 ASIA-PACIFIC TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 32 ASIA-PACIFIC NEBULIZERS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 33 ASIA-PACIFIC TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 34 ASIA-PACIFIC TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 35 ASIA-PACIFIC ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 36 ASIA-PACIFIC OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 37 ASIA-PACIFIC IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 38 ASIA-PACIFIC TOPICAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 39 ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 40 ASIA-PACIFIC HOSPITALS IN DRUG DELIVERY MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 41 ASIA-PACIFIC HOME HEALTHCARE IN DRUG DELIVERY DEVICES MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 42 ASIA-PACIFIC CLINICS IN DRUG DELIVERY DEVICES MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 43 ASIA-PACIFIC COMMUNITY HEALTHCARE IN DRUG DELIVERY DEVICES MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 44 ASIA-PACIFIC OTHERS IN DRUG DELIVERY DEVICES MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 45 ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 46 ASIA-PACIFIC DIRECT TENDERS IN DRUG DELIVERY DEVICES MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 47 ASIA-PACIFIC HOSPITAL PHARMACIES IN DRUG DELIVERY DEVICES MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 48 ASIA-PACIFIC PHARMACY STORES IN DRUG DELIVERY DEVICES MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 49 ASIA-PACIFIC ONLINE PHARMACY IN DRUG DELIVERY DEVICES MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 50 ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET, BY COUNTRY, 2022-2031 (USD MILLION)

TABLE 51 ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 52 ASIA-PACIFIC ORAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 53 ASIA-PACIFIC SOLID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 54 ASIA-PACIFIC LIQUID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 55 ASIA-PACIFIC SEMI SOLID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 56 ASIA-PACIFIC INJECTABLE DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 57 ASIA-PACIFIC INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 58 ASIA-PACIFIC INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 59 ASIA-PACIFIC CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2022-2031 (USD MILLION)

TABLE 60 ASIA-PACIFIC CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 61 ASIA-PACIFIC CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY USABILITY, 2022-2031 (USD MILLION)

TABLE 62 ASIA-PACIFIC SELF INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY USABILITY, 2022-2031 (USD MILLION)

TABLE 63 ASIA-PACIFIC TOPICAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 64 ASIA-PACIFIC TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 65 ASIA-PACIFIC SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 66 ASIA-PACIFIC LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 67 ASIA-PACIFIC SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 68 ASIA-PACIFIC OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 69 ASIA-PACIFIC OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 70 ASIA-PACIFIC LIQUID OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 71 ASIA-PACIFIC SEMI-SOLID OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 72 ASIA-PACIFIC NASAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 73 ASIA-PACIFIC PULMONARY DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 74 ASIA-PACIFIC NEBULIZERS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 75 ASIA-PACIFIC TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 76 ASIA-PACIFIC ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 77 ASIA-PACIFIC OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 78 ASIA-PACIFIC IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 79 ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 80 ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 81 JAPAN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 82 JAPAN ORAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 83 JAPAN SOLID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 84 JAPAN LIQUID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 85 JAPAN SEMI SOLID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 86 JAPAN INJECTABLE DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 87 JAPAN INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 88 JAPAN INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 89 JAPAN CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2022-2031 (USD MILLION)

TABLE 90 JAPAN CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 91 JAPAN CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY USABILITY, 2022-2031 (USD MILLION)

TABLE 92 JAPAN SELF INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY USABILITY, 2022-2031 (USD MILLION)

TABLE 93 JAPAN TOPICAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 94 JAPAN TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 95 JAPAN SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 96 JAPAN LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 97 JAPAN SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 98 JAPAN OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 99 JAPAN OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 100 JAPAN LIQUID OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 101 JAPAN SEMI-SOLID OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 102 JAPAN NASAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 103 JAPAN PULMONARY DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 104 JAPAN NEBULIZERS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 105 JAPAN TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 106 JAPAN ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 107 JAPAN OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 108 JAPAN IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 109 JAPAN DRUG DELIVERY DEVICES MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 110 JAPAN DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 111 CHINA DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 112 CHINA ORAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 113 CHINA SOLID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 114 CHINA LIQUID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 115 CHINA SEMI SOLID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 116 CHINA INJECTABLE DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 117 CHINA INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 118 CHINA INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 119 CHINA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2022-2031 (USD MILLION)

TABLE 120 CHINA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 121 CHINA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY USABILITY, 2022-2031 (USD MILLION)

TABLE 122 CHINA SELF INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY USABILITY, 2022-2031 (USD MILLION)

TABLE 123 CHINA TOPICAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 124 CHINA TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 125 CHINA SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 126 CHINA LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 127 CHINA SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 128 CHINA OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 129 CHINA OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 130 CHINA LIQUID OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 131 CHINA SEMI-SOLID OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 132 CHINA NASAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 133 CHINA PULMONARY DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 134 CHINA NEBULIZERS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 135 CHINA TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 136 CHINA ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 137 CHINA OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 138 CHINA IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 139 CHINA DRUG DELIVERY DEVICES MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 140 CHINA DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 141 INDIA DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 142 INDIA ORAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 143 INDIA SOLID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 144 INDIA LIQUID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 145 INDIA SEMI SOLID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 146 INDIA INJECTABLE DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 147 INDIA INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 148 INDIA INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 149 INDIA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2022-2031 (USD MILLION)

TABLE 150 INDIA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 151 INDIA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY USABILITY, 2022-2031 (USD MILLION)

TABLE 152 INDIA SELF INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY USABILITY, 2022-2031 (USD MILLION)

TABLE 153 INDIA TOPICAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 154 INDIA TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 155 INDIA SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 156 INDIA LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 157 INDIA SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 158 INDIA OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 159 INDIA OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 160 INDIA LIQUID OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 161 INDIA SEMI-SOLID OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 162 INDIA NASAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 163 INDIA PULMONARY DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 164 INDIA NEBULIZERS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 165 INDIA TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 166 INDIA ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 167 INDIA OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 168 INDIA IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 169 INDIA DRUG DELIVERY DEVICES MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 170 INDIA DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 171 SOUTH KOREA DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 172 SOUTH KOREA ORAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 173 SOUTH KOREA SOLID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 174 SOUTH KOREA LIQUID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 175 SOUTH KOREA SEMI SOLID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 176 SOUTH KOREA INJECTABLE DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 177 SOUTH KOREA INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 178 SOUTH KOREA INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 179 SOUTH KOREA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2022-2031 (USD MILLION)

TABLE 180 SOUTH KOREA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 181 SOUTH KOREA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY USABILITY, 2022-2031 (USD MILLION)

TABLE 182 SOUTH KOREA SELF INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY USABILITY, 2022-2031 (USD MILLION)

TABLE 183 SOUTH KOREA TOPICAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 184 SOUTH KOREA TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 185 SOUTH KOREA SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 186 SOUTH KOREA LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 187 SOUTH KOREA SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 188 SOUTH KOREA OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 189 SOUTH KOREA OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 190 SOUTH KOREA LIQUID OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 191 SOUTH KOREA SEMI-SOLID OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 192 SOUTH KOREA NASAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 193 SOUTH KOREA PULMONARY DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 194 SOUTH KOREA NEBULIZERS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 195 SOUTH KOREA TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 196 SOUTH KOREA ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 197 SOUTH KOREA OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 198 SOUTH KOREA IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 199 SOUTH KOREA DRUG DELIVERY DEVICES MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 200 SOUTH KOREA DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 201 AUSTRALIA DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 202 AUSTRALIA ORAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 203 AUSTRALIA SOLID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 204 AUSTRALIA LIQUID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 205 AUSTRALIA SEMI SOLID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 206 AUSTRALIA INJECTABLE DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 207 AUSTRALIA INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 208 AUSTRALIA INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 209 AUSTRALIA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2022-2031 (USD MILLION)

TABLE 210 AUSTRALIA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 211 AUSTRALIA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY USABILITY, 2022-2031 (USD MILLION)

TABLE 212 AUSTRALIA SELF INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY USABILITY, 2022-2031 (USD MILLION)

TABLE 213 AUSTRALIA TOPICAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 214 AUSTRALIA TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 215 AUSTRALIA SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 216 AUSTRALIA LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 217 AUSTRALIA SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 218 AUSTRALIA OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 219 AUSTRALIA OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 220 AUSTRALIA LIQUID OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 221 AUSTRALIA SEMI-SOLID OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 222 AUSTRALIA NASAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 223 AUSTRALIA PULMONARY DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 224 AUSTRALIA NEBULIZERS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 225 AUSTRALIA TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 226 AUSTRALIA ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 227 AUSTRALIA OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 228 AUSTRALIA IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 229 AUSTRALIA DRUG DELIVERY DEVICES MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 230 AUSTRALIA DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 231 THAILAND DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 232 THAILAND ORAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 233 THAILAND SOLID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 234 THAILAND LIQUID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 235 THAILAND SEMI SOLID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 236 THAILAND INJECTABLE DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 237 THAILAND INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 238 THAILAND INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 239 THAILAND CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2022-2031 (USD MILLION)

TABLE 240 THAILAND CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 241 THAILAND CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY USABILITY, 2022-2031 (USD MILLION)

TABLE 242 THAILAND SELF INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY USABILITY, 2022-2031 (USD MILLION)

TABLE 243 THAILAND TOPICAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 244 THAILAND TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 245 THAILAND SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 246 THAILAND LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 247 THAILAND SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 248 THAILAND OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 249 THAILAND OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 250 THAILAND LIQUID OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 251 THAILAND SEMI-SOLID OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 252 THAILAND NASAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 253 THAILAND PULMONARY DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 254 THAILAND NEBULIZERS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 255 THAILAND TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 256 THAILAND ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 257 THAILAND OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 258 THAILAND IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 259 THAILAND DRUG DELIVERY DEVICES MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 260 THAILAND DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 261 MALAYSIA DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 262 MALAYSIA ORAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 263 MALAYSIA SOLID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 264 MALAYSIA LIQUID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 265 MALAYSIA SEMI SOLID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 266 MALAYSIA INJECTABLE DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 267 MALAYSIA INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 268 MALAYSIA INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 269 MALAYSIA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2022-2031 (USD MILLION)

TABLE 270 MALAYSIA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 271 MALAYSIA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY USABILITY, 2022-2031 (USD MILLION)

TABLE 272 MALAYSIA SELF INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY USABILITY, 2022-2031 (USD MILLION)

TABLE 273 MALAYSIA TOPICAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 274 MALAYSIA TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 275 MALAYSIA SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 276 MALAYSIA LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 277 MALAYSIA SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 278 MALAYSIA OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 279 MALAYSIA OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 280 MALAYSIA LIQUID OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 281 MALAYSIA SEMI-SOLID OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 282 MALAYSIA NASAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 283 MALAYSIA PULMONARY DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 284 MALAYSIA NEBULIZERS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 285 MALAYSIA TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 286 MALAYSIA ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 287 MALAYSIA OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 288 MALAYSIA IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 289 MALAYSIA DRUG DELIVERY DEVICES MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 290 MALAYSIA DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 291 SINGAPORE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 292 SINGAPORE ORAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 293 SINGAPORE SOLID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 294 SINGAPORE LIQUID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 295 SINGAPORE SEMI SOLID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 296 SINGAPORE INJECTABLE DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 297 SINGAPORE INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 298 SINGAPORE INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 299 SINGAPORE CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2022-2031 (USD MILLION)

TABLE 300 SINGAPORE CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 301 SINGAPORE CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY USABILITY, 2022-2031 (USD MILLION)

TABLE 302 SINGAPORE SELF INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY USABILITY, 2022-2031 (USD MILLION)

TABLE 303 SINGAPORE TOPICAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 304 SINGAPORE TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 305 SINGAPORE SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 306 SINGAPORE LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 307 SINGAPORE SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 308 SINGAPORE OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 309 SINGAPORE OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 310 SINGAPORE LIQUID OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 311 SINGAPORE SEMI-SOLID OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 312 SINGAPORE NASAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 313 SINGAPORE PULMONARY DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 314 SINGAPORE NEBULIZERS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 315 SINGAPORE TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 316 SINGAPORE ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 317 SINGAPORE OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 318 SINGAPORE IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 319 SINGAPORE DRUG DELIVERY DEVICES MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 320 SINGAPORE DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 321 INDONESIA DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 322 INDONESIA ORAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 323 INDONESIA SOLID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 324 INDONESIA LIQUID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 325 INDONESIA SEMI SOLID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 326 INDONESIA INJECTABLE DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 327 INDONESIA INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 328 INDONESIA INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 329 INDONESIA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2022-2031 (USD MILLION)

TABLE 330 INDONESIA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 331 INDONESIA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY USABILITY, 2022-2031 (USD MILLION)

TABLE 332 INDONESIA SELF INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY USABILITY, 2022-2031 (USD MILLION)

TABLE 333 INDONESIA TOPICAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 334 INDONESIA TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 335 INDONESIA SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 336 INDONESIA LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 337 INDONESIA SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 338 INDONESIA OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 339 INDONESIA OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 340 INDONESIA LIQUID OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 341 INDONESIA SEMI-SOLID OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 342 INDONESIA NASAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 343 INDONESIA PULMONARY DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 344 INDONESIA NEBULIZERS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 345 INDONESIA TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 346 INDONESIA ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 347 INDONESIA OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 348 INDONESIA IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 349 INDONESIA DRUG DELIVERY DEVICES MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 350 INDONESIA DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 351 PHILIPPINES DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 352 PHILIPPINES ORAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 353 PHILIPPINES SOLID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 354 PHILIPPINES LIQUID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 355 PHILIPPINES SEMI SOLID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 356 PHILIPPINES INJECTABLE DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 357 PHILIPPINES INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 358 PHILIPPINES INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 359 PHILIPPINES CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2022-2031 (USD MILLION)

TABLE 360 PHILIPPINES CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 361 PHILIPPINES CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY USABILITY, 2022-2031 (USD MILLION)

TABLE 362 PHILIPPINES SELF INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY USABILITY, 2022-2031 (USD MILLION)

TABLE 363 PHILIPPINES TOPICAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 364 PHILIPPINES TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 365 PHILIPPINES SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 366 PHILIPPINES LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 367 PHILIPPINES SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 368 PHILIPPINES OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 369 PHILIPPINES OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 370 PHILIPPINES LIQUID OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 371 PHILIPPINES SEMI-SOLID OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 372 PHILIPPINES NASAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 373 PHILIPPINES PULMONARY DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 374 PHILIPPINES NEBULIZERS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 375 PHILIPPINES TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 376 PHILIPPINES ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 377 PHILIPPINES OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 378 PHILIPPINES IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 379 PHILIPPINES DRUG DELIVERY DEVICES MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 380 PHILIPPINES DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 381 REST OF ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

図表一覧

FIGURE 1 ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET: SEGMENTATION

FIGURE 2 ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET: DATA TRIANGULATION

FIGURE 3 ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET: DROC ANALYSIS

FIGURE 4 ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET: ASIA-PACIFIC VS REGIONAL MARKET ANALYSIS

FIGURE 5 ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET: MARKET END USER COVERAGE GRID

FIGURE 8 ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET: DBMR MARKET POSITION GRID

FIGURE 9 ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET: SEGMENTATION

FIGURE 11 EXECUTIVE SUMMARY

FIGURE 12 EIGHT SEGMENTS COMPRISE THE ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE

FIGURE 13 STRATEGIC DECISIONS

FIGURE 14 RISING PREVALENCE OF CHRONIC DISEASE AND NON-CHRONIC DISEASE ARE DRIVING THE GROWTH OF THE ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET FROM 2024 TO 2031

FIGURE 15 THE ORAL DRUG DELIVERY SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET IN 2024 AND 2031

FIGURE 16 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET

FIGURE 17 ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET: BY PRODUCT TYPE, 2023

FIGURE 18 ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET: BY PRODUCT TYPE, 2023-2031 (USD MILLION)

FIGURE 19 ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET: BY PRODUCT TYPE, CAGR (2024-2031)

FIGURE 20 ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET: BY PRODUCT TYPE, LIFELINE CURVE

FIGURE 21 ASIA-PACIFIC DRUG DELIVERY MARKET: BY END USER, 2023

FIGURE 22 ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET: BY END USER, 2024-2031 (USD MILLION)

FIGURE 23 ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET: END USER, CAGR (2024-2031)

FIGURE 24 ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET: END USER, LIFELINE CURVE

FIGURE 25 ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET: BY DISTRIBUTION CHANNEL, 2023

FIGURE 26 ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET: BY DISTRIBUTION CHANNEL, 2024-2031 (USD MILLION)

FIGURE 27 ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET: BY DISTRIBUTION CHANNEL, CAGR (2024-2031)

FIGURE 28 ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 29 ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET: SNAPSHOT (2023)

FIGURE 30 ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET: COMPANY SHARE 2023 (%)

詳細情報を見る Right Arrow

調査方法

データ収集と基準年分析は、大規模なサンプル サイズのデータ​​収集モジュールを使用して行われます。この段階では、さまざまなソースと戦略を通じて市場情報または関連データを取得します。過去に取得したすべてのデータを事前に調査および計画することも含まれます。また、さまざまな情報ソース間で見られる情報の不一致の調査も含まれます。市場データは、市場統計モデルと一貫性モデルを使用して分析および推定されます。また、市場シェア分析と主要トレンド分析は、市場レポートの主要な成功要因です。詳細については、アナリストへの電話をリクエストするか、お問い合わせをドロップダウンしてください。

DBMR 調査チームが使用する主要な調査方法は、データ マイニング、データ変数が市場に与える影響の分析、および一次 (業界の専門家) 検証を含むデータ三角測量です。データ モデルには、ベンダー ポジショニング グリッド、市場タイムライン分析、市場概要とガイド、企業ポジショニング グリッド、特許分析、価格分析、企業市場シェア分析、測定基準、グローバルと地域、ベンダー シェア分析が含まれます。調査方法について詳しくは、お問い合わせフォームから当社の業界専門家にご相談ください。

カスタマイズ可能

Data Bridge Market Research は、高度な形成的調査のリーダーです。当社は、既存および新規のお客様に、お客様の目標に合致し、それに適したデータと分析を提供することに誇りを持っています。レポートは、対象ブランドの価格動向分析、追加国の市場理解 (国のリストをお問い合わせください)、臨床試験結果データ、文献レビュー、リファービッシュ市場および製品ベース分析を含めるようにカスタマイズできます。対象競合他社の市場分析は、技術ベースの分析から市場ポートフォリオ戦略まで分析できます。必要な競合他社のデータを、必要な形式とデータ スタイルでいくつでも追加できます。当社のアナリスト チームは、粗い生の Excel ファイル ピボット テーブル (ファクト ブック) でデータを提供したり、レポートで利用可能なデータ セットからプレゼンテーションを作成するお手伝いをしたりすることもできます。

Frequently Asked Questions

The market is segmented based on Asia-Pacific Drug Delivery Devices Market, By Product Type (Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ophthalmic Drug Delivery, Nasal Drug Delivery, Pulmonary Drug Delivery, Transmucosal Drug Delivery, and Implantable Drug Delivery), End User (Hospitals, Home Healthcare, Clinics, Community Healthcare and Others), Distribution Channel (Direct Tenders, Hospital Pharmacies, Pharmacy Stores, and Online Pharmacy) - Industry Trends and Forecast to 2031. .
The Asia Pacific Apac Drug Delivery Devices Market size was valued at USD 320.82 USD Billion in 2023.
The Asia Pacific Apac Drug Delivery Devices Market is projected to grow at a CAGR of 9.9% during the forecast period of 2024 to 2031.
The major players operating in the market include , F. Hoffmann,La Roche , Mylan N.V. , Teva Pharmaceutical Industries , Sanofi , Pfizer , GlaxoSmithKline plc , Novartis AG , Sun Pharmaceutical Industries , Dr. Reddy's Laboratories , Bausch Health Companies , AstraZeneca , Johnson & Johnson Private Limited , Merck & Co. , Cadila Pharmaceuticals. , 3M , Bayer AG , Astellas Pharma , AbbVie , Takeda Pharmaceutical Company Limited ,.
The market report covers data from the Japan, China, South Korea, India, Singapore, Thailand, Indonesia, Malaysia, Philippines, Australia, and rest of Asia-Pacific.

関連ページを閲覧する

Banner